FDANonrulemakingFDA-2023-N-0743

Who commented on this docket

Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products; Availability

3 organizations filed 4 public comments on Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products; Availability, at the Food and Drug Administration. The comment window closed 1084d ago.

Organizations
3
Comments
4
RIN
Comment window
closed 1084d ago

Abstract

OPEN

Commenters (3)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.

Who Commented on Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products; Availability (FDA-2023-N-0743) | OpenPolis